Skip to content

A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment

A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00702065
Acronym
MusiQoL
Enrollment
599
Registered
2008-06-20
Start date
2007-11-30
Completion date
2010-10-31
Last updated
2014-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Multiple Sclerosis Quality of life

Brief summary

This is a multi-center, multi-regional observational,24 month study. Health-related quality of life data from the MusiQoL instrument and SF-36 instrument will be collected at baseline, M6, M12, M18 and M24 in patients with MS. In addition, physical health outcomes such as expanded disability status scores (EDSS) will be collected every 6 months.

Detailed description

This is a multi-center, multi-regional observational,24 month study. Health-related quality of life data from the MusiQoL instrument and SF-36 instrument will be collected at baseline, M6, M12, M18 and M24 in patients with MS. In addition, physical health outcomes such as expanded disability status scores (EDSS) will be collected every 6 months.

Interventions

None listed

Sponsors

EMD Serono
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient has any form of MS (confirmed by McDonald and/or Poser criteria) 2. Patient is 18 years old or more (inclusive, at time of informed consent). 3. Patient has an EDSS score lower than 7.0 (inclusive, at time of informed consent) 4. Patient can be with or without treatment 5. Patient has read, understood, signed and dated informed consent form 6. Patient is able to fill in the questionnaire by him/herself

Exclusion criteria

1. CIS Patient (MS not confirmed by Mc Donald and /or Poser criteria) 2. Patient receives or is planned to receive during the course of this study any investigational drug or experimental procedure 3. Patient suffers from dementia in the opinion of the investigator 4. Patient suffers of major medical or psychiatric illness in the opinion of the investigator

Design outcomes

Primary

MeasureTime frame
MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) ScoreMonth 24

Countries

Argentina, Australia, Austria, France, Germany, Israel, Italy, Norway, Spain, Turkey (Türkiye), United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026